OBINUTUZUMAB WITH MYCOPHENOLATE MOFETIL

Clinical Indication

for treating lupus nephritis

Comments

In line with NICE TA1131

Funding: 12th May 2026

Date of classification

April 2026

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.